Urmăriți
Emily Hankosky
Titlu
Citat de
Citat de
Anul
Chronic stress causes amygdala hyperexcitability in rodents
JA Rosenkranz, ER Venheim, M Padival
Biological psychiatry 67 (12), 1128-1136, 2010
3012010
The changing landscape of naloxone availability in the United States, 2011–2017
PR Freeman, ER Hankosky, MR Lofwall, JC Talbert
Drug and alcohol dependence 191, 361-364, 2018
902018
Age and sex differences in behavioral flexibility, sensitivity to reward value, and risky decision-making.
SR Westbrook, ER Hankosky, MR Dwyer, JM Gulley
Behavioral Neuroscience 132 (2), 75, 2018
412018
Age of exposure-dependent effects of amphetamine on behavioral flexibility
ER Hankosky, NM Kofsky, JM Gulley
Behavioural brain research 252, 117-125, 2013
362013
Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence
ER Hankosky, JM Gulley
Developmental psychobiology 55 (7), 733-744, 2013
332013
Pharmacological enhancement of calcium-activated potassium channel function reduces the effects of repeated stress on fear memory
D Atchley, ER Hankosky, K Gasparotto, JA Rosenkranz
Behavioural brain research 232 (1), 37-43, 2012
272012
Beta-hydroxy-beta-methylbutyrate ameliorates aging effects in the dendritic tree of pyramidal neurons in the medial prefrontal cortex of both male and female rats
DG Kougias, SO Nolan, WA Koss, T Kim, ER Hankosky, JM Gulley, ...
Neurobiology of aging 40, 78-85, 2016
262016
Effects of β-hydroxy-β-methyl butyrate on working memory and cognitive flexibility in an animal model of aging
ER Hankosky, LK Sherrill, LA Ruvola, RM Haake, T Kim, LR Hammerslag, ...
Nutritional Neuroscience 20 (7), 379-387, 2017
242017
D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence
S Kang, K Paul, ER Hankosky, CL Cox, JM Gulley
Neuroscience 324, 40-49, 2016
212016
Risk factors associated with COVID-19 hospitalization and mortality: a large claims-based analysis among people with type 2 diabetes mellitus in the United States
KS Boye, E Tokar Erdemir, N Zimmerman, A Reddy, BD Benneyworth, ...
Diabetes Therapy 12, 2223-2239, 2021
202021
Age-and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT2C receptor localization in the orbitofrontal cortex of Sprague-Dawley rats
ER Hankosky, SR Westbrook, RM Haake, J Willing, LT Raetzman, ...
Behavioural brain research 349, 16-24, 2018
182018
Retrospective analysis of health claims to evaluate pharmacotherapies with potential for repurposing: Association of bupropion and stimulant use disorder remission
ER Hankosky, HM Bush, LP Dwoskin, DR Harris, DW Henderson, ...
AMIA Annual Symposium Proceedings 2018, 1292, 2018
172018
X-search: an open access interface for cross-cohort exploration of the National Sleep Research Resource
L Cui, N Zeng, M Kim, R Mueller, ER Hankosky, S Redline, GQ Zhang
BMC medical informatics and decision making 18, 1-10, 2018
162018
Reduced sensitivity to reinforcement in adolescent compared to adult Sprague-Dawley rats of both sexes
ER Hankosky, SR Westbrook, RM Haake, M Marinelli, JM Gulley
Psychopharmacology 235, 861-871, 2018
152018
Beta-hydroxy-beta-methylbutyrate (HMB) ameliorates age-related deficits in water maze performance, especially in male rats
DG Kougias, ER Hankosky, JM Gulley, JM Juraska
Physiology & behavior 170, 93-99, 2017
142017
Association between state Medicaid expansion status and naloxone prescription dispensing
M Sohn, JC Talbert, C Delcher, ER Hankosky, MR Lofwall, PR Freeman
Health services research 55 (2), 239-248, 2020
132020
Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in Truven
S Fouladvand, ER Hankosky, H Bush, J Chen, LP Dwoskin, PR Freeman, ...
Health informatics journal 26 (2), 787-802, 2020
112020
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: an indirect treatment comparison
CW le Roux, ER Hankosky, D Wang, R Malik, M Yu, A Hickey, H Kan, ...
Diabetes, Obesity and Metabolism 25 (9), 2626-2633, 2023
82023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post …
ER Hankosky, H Wang, LM Neff, H Kan, F Wang, NN Ahmad, R Griffin, ...
Diabetes, Obesity and Metabolism 26 (1), 319-328, 2024
72024
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial
ER Hankosky, H Wang, LM Neff, H Kan, F Wang, NN Ahmad, A Stefanski, ...
Diabetes, Obesity and Metabolism 25 (12), 3748-3756, 2023
52023
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20